After five years of treating foreign investment with growing arrogance, the newly-impoverished Russian government is putting on its best smile to try to attract long-term capital into the country. Will it succeed? Julian Evans reports.
Latvia was one of the countries hardest hit by the global crisis. Now there are concerns about the knock-on effect a devaluation of its currency would have on neighbouring economies. Eva-Luise Schwarz reports.
It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.
Despite the economic slump, canny acquirers have proved that there are still M&A deals to be done. Tim Burke speaks to the CEOs behind some of the year’s biggest emerging market transactions – and finds that for many, the crisis had a silver lining.